Treating anisometropic amblyopia with a dichoptic digital platform
The investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age
Distorted corneas: How to regularise them with minimally invasive surgery
Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations
US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents
Industry-sponsored satellite symposia at the 23rd EURETINA Congress
Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world
23rd annual EURETINA Congress: seeing eye to eye in Amsterdam
Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops
ESCRS 2023: Olivier Benoit says Ciliatech’s glaucoma implant defied his expectations
In the years to come, Ciliatech will release more data around their novel Cilioscleral Interposition Device (CID)
ESCRS 2023: Talking next-generation femtosecond lasers for corneal refractive surgery with Prof Rohit Shetty
The future of refractive surgery is bright, thanks to OCTs and advances in laser technology
ESCRS 2023: Ana Neves explains the strategy behind the workflow-oriented ZEISS booth
At the meeting, ZEISS Meditec Ophthalmology showcased the VISUMAX 800 and a host of new launches
ESCRS 2023: Dr Amir Hamid praises the wide range of technologies on view
The medical director for Optegra has piloted corneal workflows and trifocal lenses presented at the meeting
ESCRS 2023: Fritz Hengerer, MD, PhD, presents new data for cataract surgeons
The director of Frankfurt’s Bürgerhospital eye hospital shared 7 years’ data on the iStent inject®
Study: Children with vision impairment have reduced quality of life
Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems
ESCRS 2023: The three things that make this meeting a priority for Dr Sheng Lim
The glaucoma specialist spoke about his ESCRS agenda–and his calendar for 2024
Intravitreal cell therapy as protection from degenerations
Stem cells may replace some lost retinal neurons
ESCRS 2023: New artificial intelligence integrations are ahead for iCare
The diagnostics company is using AI to screen for diabetic retinopathy, glaucoma and age-related macular degeneration
ESCRS 2023: Scott D. Barnes, MD, looks to the future of user-friendly lens injectors
New cataract and refractive options from STAAR Surgical could come as early as this year
RETFound: New AI model to detect retinal disease biomarkers developed by Moorfields Eye Hospital
The AI retinal scanning model will be free to use for all institutions
ESCRS 2023: Device-centric focus drives a redesign at Geuder
Two members of the team gave a preview of Geuder’s 2024 spotlight products
ESCRS 2023: Data-driven innovation in the glaucoma space with Keith Barton
As part of the meeting’s MIGS programme, Keith Barton, MD, FRCP, FRCS, FRCOphth, shared data from the iTrack™ Global Data Registry
ESCRS 2023: Orbis International details new education partnership and celebrates 20 years of Cybersight
The nonprofit marked a major milestone by announcing a suite of webinars with Heidelberg Engineering
Study: MERCURY-3 trial results support efficacy of Roclanda
MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.
ESCRS 2023: Managing directors from Heidelberg Engineering preview Orbis partnership
The diagnostic imaging experts will provide education through the Cybersight platform
ESCRS 2023: Greg Kunst looks ahead at the next 5 years of Aurion Biotech’s cell therapies
In a conversation at ESCRS, the CEO said by 2028, Aurion Biotech hopes to see global registration for its corneal endothelial disease therapies.
Syncona announces Novartis will discontinue development of GT005 for geographic atrophy
Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022
Bausch + Lomb launches MIEBO (perfluorohexyloctane ophthalmic solution) in US
According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution), commercialised as EvoTears in Europe, is the first prescription eye drop that targets tear evaporation.
ESCRS 2023: Thomas Bosshard discusses Oertli's 3-platform approach
At this year's ESCRS meeting, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach.
ESCRS 2023: Krysten Williams talks about bringing Heidelberg image quality into the surgical theater
At the 2023 European Society Of Cataract & Refractive Surgeons (ESCRS) meeting in Vienna, Krysten Williams, head of marketing and education at Heidelberg Engineering, spoke to our team about the newest imaging advancements in the clinic and the operating room.
ESCRS 2023: Binkhorst Medal lecture addresses the future of cataract and refractive surgery
Jorge Alio, MD, PhD, FEBOpthhal spoke with our team about his Binkhorst Medal lecture topic, the future of cataract and refractive surgery, while at the 2023 ESCRS meeting in Vienna, Austria.
ESCRS 2023: Integrated workflow solutions in cataract procedures
Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.
Orbis and Heidelberg Engineering announce new partnership at ESCRS congress
The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.
Ciliatech presents clinical trial results from SAFARI III glaucoma study
The company announced new data on outcomes for both open and narrow angle glaucoma patients.
2 Clarke Drive Cranbury, NJ 08512